SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,179,616 | -5.6% | 397,456 | -10.8% | 0.28% | -3.1% |
| Q2 2023 | $51,027,020 | -23.2% | 445,573 | -7.6% | 0.29% | -27.8% |
| Q1 2023 | $66,433,509 | +7.7% | 481,996 | +1.3% | 0.41% | -2.4% |
| Q4 2022 | $61,667,252 | +11.1% | 475,901 | -5.2% | 0.42% | -5.0% |
| Q3 2022 | $55,512,000 | +69.9% | 502,193 | +15.2% | 0.44% | +73.5% |
| Q2 2022 | $32,668,000 | -4.5% | 435,810 | -0.5% | 0.25% | +10.0% |
| Q1 2022 | $34,220,000 | -11.4% | 438,045 | +2.2% | 0.23% | -11.2% |
| Q4 2021 | $38,607,000 | +326.9% | 428,734 | +338.4% | 0.26% | +324.6% |
| Q3 2021 | $9,043,000 | +25.1% | 97,785 | +5.2% | 0.06% | +24.5% |
| Q2 2021 | $7,226,000 | +8.9% | 92,950 | +4.4% | 0.05% | -3.9% |
| Q1 2021 | $6,633,000 | +1305.3% | 88,997 | +2924.0% | 0.05% | +920.0% |
| Q2 2020 | $472,000 | +35.2% | 2,943 | -83.9% | 0.01% | -28.6% |
| Q2 2016 | $349,000 | – | 18,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |